Search Results
… CA Astrocyte regulation of neural plasticity after CNS injury NINDS K99/R00 Awardee – January 2018 Independent … mechanisms that regulate spontaneous recovery after spinal cord injury. Joshua received his Ph.D. in Molecular …
… of rigor and ethics demanded in the lab, but in the fact that the lessons imparted to them from adhering to these … interested in their role in chronic pain and psychiatric disorders. … …
… On this page What is lateral medullary syndrome? Lateral medullary syndrome is a neurological condition caused by a stroke in … between the brain and spinal cord. Lateral medullary syndrome is also known as Wallenberg's syndrome or PICA …
… to reducing that burden through biomedical research. What is Stroke? A stroke, or "brain attack," occurs when … of oxygen. There are two broad categories of stroke: those caused by a blockage of blood flow and those caused by … risk of death or disability from stroke: control stroke's risk factors and know stroke's warning signs. Scientific …
… and implementation of protocols in neurological disorders affecting adult and/or pediatric populations. The … therapeutics (drugs, biologics, devices) for neurological disorders. These novel therapeutics may come from academic … NINDS Director following National Advisory Neurological Disorders and Stroke Council review. NeuroNEXT Small Business …
On this page
What is kuru?
Kuru is a rare and fatal brain disorder that occurred at epidemic levels from the 1950s to 1960s among the Fore people in the highlands of New Guinea. The disease was the result of the practice of ritualistic cannibalism among the Fore, in which relatives prepared and consumed the tissues (including brain) of deceased family members. Brain tissue from individuals with kuru was highly infectious, and the disease was transmitted either through eating or by contact with open sores or wounds. Kuru is…
… including stroke, multiple sclerosis, and brain and spinal cord injuries. By studying neurovascular interactions through …
… Amyotrophic lateral sclerosis (ALS) is a devastating, complex, and heterogeneous … and three disease-modifying, plus one symptom-managing, ALS therapies have been approved by the Food and Drug Administration (FDA). Yet, to develop truly effective ALS treatments, we must address numerous challenges. Join …
… trials are studies that allow us to learn more about disorders and improve care. They can help connect patients … and scientists can learn more about AT and related disorders. Clinical research uses human volunteers to help …
… a period of impressive growth and is attracting the brightest and most enthusiastic students of any area of science. The … number of NIH-supported trainees graduating with a Ph.D. in neuroscience has sky-rocketed since 2001. These young …